PROMIS NEUROSCIENCES INC. Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option
PROMIS NEUROSCIENCES INC. (PMN) reported Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option of $43.49 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Notes
us-gaap:IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption · last filed 2024-08-08
- PROMIS NEUROSCIENCES INC. increase (decrease) in fair value adjustments on other assets (liabilities) carried at fair value under fair value option for the quarter ending 2024-06-30 was -$251.48K.
- PROMIS NEUROSCIENCES INC. increase (decrease) in fair value adjustments on other assets (liabilities) carried at fair value under fair value option for the quarter ending 2024-03-31 was $294.97K.
USD
| Period end | Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option 3 month | Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option 6 month | Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option 9 month |
|---|---|---|---|
| 2024-06-30 | -$251.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $43.49K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $294.97K 10-Q · filed 2024-05-14 | ||
| 2023-09-30 | $776.15K 10-Q · filed 2023-11-14 |
CAD
| Period end | Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option 12 month |
|---|---|
| 2023-12-31 | 1.01M CAD 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |